A detailed history of Susquehanna International Group, LLP transactions in Cara Therapeutics, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 61,815 shares of CARA stock, worth $16,071. This represents 0.0% of its overall portfolio holdings.

Number of Shares
61,815
Previous 45,678 35.33%
Holding current value
$16,071
Previous $33,000 69.7%
% of portfolio
0.0%
Previous 0.0%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024

BUY
$0.52 - $1.05 $8,391 - $16,943
16,137 Added 35.33%
61,815 $56,000
Q4 2023

Feb 14, 2024

SELL
$0.6 - $1.65 $144,843 - $398,319
-241,406 Reduced 84.09%
45,678 $33,000
Q3 2023

Nov 14, 2023

BUY
$1.67 - $3.33 $47,783 - $95,281
28,613 Added 11.07%
287,084 $482,000
Q2 2023

Aug 11, 2023

BUY
$2.83 - $4.94 $577,936 - $1.01 Million
204,218 Added 376.42%
258,471 $731,000
Q1 2023

May 16, 2023

BUY
$4.89 - $12.27 $265,297 - $665,684
54,253 New
54,253 $266,000
Q3 2022

Nov 14, 2022

SELL
$8.24 - $12.56 $58,973 - $89,891
-7,157 Reduced 9.61%
67,326 $630,000
Q2 2022

Aug 15, 2022

BUY
$7.45 - $13.84 $118,775 - $220,651
15,943 Added 27.23%
74,483 $680,000
Q1 2022

May 16, 2022

SELL
$9.94 - $12.65 $2.24 Million - $2.85 Million
-225,428 Reduced 79.39%
58,540 $711,000
Q4 2021

Feb 14, 2022

BUY
$11.99 - $18.14 $772,371 - $1.17 Million
64,418 Added 29.34%
283,968 $3.46 Million
Q3 2021

Nov 15, 2021

BUY
$11.55 - $16.06 $1.06 Million - $1.47 Million
91,832 Added 71.9%
219,550 $3.39 Million
Q2 2021

Aug 11, 2021

BUY
$12.38 - $29.19 $1.17 Million - $2.76 Million
94,680 Added 286.58%
127,718 $1.82 Million
Q1 2021

May 17, 2021

SELL
$15.07 - $21.71 $241,135 - $347,381
-16,001 Reduced 32.63%
33,038 $717,000
Q4 2020

Feb 16, 2021

SELL
$12.72 - $16.16 $268,608 - $341,250
-21,117 Reduced 30.1%
49,039 $742,000
Q3 2020

Nov 16, 2020

SELL
$12.34 - $17.92 $129,977 - $188,751
-10,533 Reduced 13.05%
70,156 $893,000
Q1 2020

May 15, 2020

SELL
$9.12 - $17.78 $394,494 - $769,091
-43,256 Reduced 34.9%
80,689 $1.07 Million
Q4 2019

Feb 14, 2020

BUY
$16.11 - $25.98 $1.12 Million - $1.81 Million
69,687 Added 128.44%
123,945 $2 Million
Q3 2019

Nov 14, 2019

SELL
$18.28 - $26.91 $5.88 Million - $8.65 Million
-321,614 Reduced 85.56%
54,258 $992,000
Q2 2019

Aug 16, 2019

BUY
$17.68 - $21.57 $206,820 - $252,325
11,698 Added 3.21%
375,872 $8.08 Million
Q2 2019

Aug 14, 2019

BUY
$17.68 - $21.57 $2.54 Million - $3.09 Million
143,392 Added 64.95%
364,174 $7.83 Million
Q1 2019

May 15, 2019

SELL
$14.41 - $19.64 $598,130 - $815,217
-41,508 Reduced 15.83%
220,782 $4.33 Million
Q4 2018

Feb 14, 2019

SELL
$12.45 - $23.47 $1.74 Million - $3.29 Million
-140,113 Reduced 34.82%
262,290 $3.41 Million
Q3 2018

Nov 14, 2018

BUY
$17.57 - $23.95 $3.95 Million - $5.39 Million
224,859 Added 126.65%
402,403 $9.64 Million
Q2 2018

Aug 14, 2018

SELL
$11.6 - $19.27 $1.31 Million - $2.18 Million
-113,323 Reduced 38.96%
177,544 $3.4 Million
Q1 2018

May 15, 2018

SELL
$11.77 - $16.08 $377,687 - $515,991
-32,089 Reduced 9.94%
290,867 $3.6 Million
Q4 2017

Feb 14, 2018

BUY
$11.86 - $14.08 $2.27 Million - $2.7 Million
191,416 Added 145.52%
322,956 $3.95 Million
Q3 2017

Nov 14, 2017

BUY
$12.6 - $16.34 $1.66 Million - $2.15 Million
131,540
131,540 $1.8 Million

Others Institutions Holding CARA

About Cara Therapeutics, Inc.


  • Ticker CARA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,725,900
  • Market Cap $14M
  • Description
  • Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...
More about CARA
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.